Navigation Links
OncoSec to Present at the Rodman & Renshaw 2012 Annual Global Investment Conference
Date:8/29/2012

SAN DIEGO, Aug. 29, 2012 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB: ONCS), a company developing its ImmunoPulse and NeoPulse therapies to treat solid tumor cancers, announced it will be presenting at the Rodman & Renshaw 2012 Annual Global Investment Conference in New York City.

Punit Dhillon, President and CEO of OncoSec, will deliver the Company presentation to conference attendees on Monday, September 10 at 3:15 PM ET in the Palm Room at the Waldorf Astoria Hotel. The presentation will also be webcast and can be viewed at this link: http://www.wsw.com/webcast/rrshq22/oncs

Mr. Dhillon said, "Presenting at the Rodman & Renshaw Global Investment Conference provides us an exciting opportunity to highlight our growing investment potential and leadership in the development of cancer therapies."

More than 300 public and private companies from around the world are registered to present in front of an audience of over 3,000 attendees. Newt Gingrich, 58th Speaker of the U.S. House of Representatives, will open the Conference as the Keynote Speaker on Monday, September 10. Conference registration details can be found at:
http://www.rodmanandrenshaw.com/conferences?id=176&link=registration

About OncoSec Medical Inc.

OncoSec Medical Incorporated is a biopharmaceutical company developing its advanced-stage OMS ElectroOncology therapies to treat solid tumor cancers and metastatic disease. OMS ElectroOncology therapies address an unmet medical need and represent a potential solution, for less invasive and less expensive therapies that are able to minimize detrimental effects resulting from currently available cancer treatments such as surgery, systemic chemotherapy or immunotherapy and other treatment alternatives.  OncoSec's core technology is
'/>"/>

SOURCE OncoSec Medical Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer
2. OncoSec Medical Issues Letter to Shareholders
3. OncoSec Presents Preliminary Safety Data for Phase II Melanoma Study at Second European Post-Chicago Melanoma Meeting 2012
4. OncoSec Establishes Clinical Site for Its Phase II Merkel Cell Carcinoma Trial at University of California San Francisco (UCSF)
5. OncoSec OMS ElectroChemotherapy for Head and Neck Cancer Shows Enhanced Quality of Life in Two Randomized Phase III Studies
6. OncoSec Featured on KTVU-TV News and in San Francisco Chronicle
7. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
8. Latest Findings in Breastfeeding Science Presented at Medelas 7th International Breastfeeding and Lactation Symposium
9. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
10. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London
11. Foundation for Managed Care Pharmacy (FMCP) Presents Awards for 2012 National P&T Competition and Best Posters
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... Sept. 19, 2014  The board of directors of ... quarterly cash dividend of $0.42 per share.  ... to stockholders of record at the close of business ... is a global, research-based biopharmaceutical company formed in 2013 ... use its expertise, dedicated people and unique approach to ...
(Date:9/19/2014)... RESEARCH TRIANGLE PARK, N.C. , Sept. 19, ... company focused on cloud-based drug design and development, ... strategy. The company,s mission is to design new ... Phase 1 and 2 partners to further their ... enhance its portfolio investments. To support this business ...
(Date:9/19/2014)... DUBLIN , Sept. 19, 2014 Research ... "Global Human Microbiome (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder) ... For the purposes of this report, the human ... The human microbiome market is expected to be ... grow at a CAGR of 22.3% within the forecast period ...
Breaking Medicine Technology:Cloud Pharmaceuticals Announces Partnering Sessions and Presentation Schedule 2Global Human Microbiome (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder) Market - Forecast to 2023 2Global Human Microbiome (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder) Market - Forecast to 2023 3
... BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) will ... community on Thursday, December 8, 2011 from 8:00 a.m. ... New York City.  Members of BioMarin,s management team and ... product portfolio and advancements in the research and development ...
... 17, 2011 Eli Lilly and Company (NYSE: ... more than $4 million in additional funding to the ... to continue its early phase drug discovery efforts focused ... against tuberculosis, including multidrug-resistant strains known as MDR-TB. In ...
Cached Medicine Technology:BioMarin to Host a Research and Development Day on December 8th 2Lilly Provides Additional Funding to Infectious Disease Research Institute to Identify New Tuberculosis Therapies 2Lilly Provides Additional Funding to Infectious Disease Research Institute to Identify New Tuberculosis Therapies 3Lilly Provides Additional Funding to Infectious Disease Research Institute to Identify New Tuberculosis Therapies 4
(Date:9/21/2014)... 21, 2014 To accommodate the ever-growing ... and provide more trendy items. Recently, the company has ... offering the new and elegant wedding gowns, Angeldress.co.uk wants ... they need in an easy way. Its high quality ... rates, from 12% off to 62% off. , Online ...
(Date:9/21/2014)... experienced review website in the global market, Top10BestSEOHosting.com, has ... that FatCow ( http://www.top10bestseohosting.com/go/FatCow.com/ ), GoDaddy and Bluehost are ... been a boom in websites in recent years, and ... the number of web hosting companies that offer a ... (Virtual Private Server) is the method of partitioning a ...
(Date:9/21/2014)... 2014 Developers and plugin specialist of ... a new transition plugin entitled Transpack Vol. 3 from ... quality transitions that will add a level of professionalism ... of Pixel Film Studios. “Blurring the line between professional ... changer.” , Transpack Vol. 3 returns with over 85 ...
(Date:9/21/2014)... According to latest National Vital Statistics Reports ... 1966 (10.5 births per 1,000 women in 2013). Since 2000, ... steadily by 2 percent per year. The birth rate for ... and over) also rose, the first such increase since 2008. ... times as many first births to women aged 35 and ...
(Date:9/20/2014)... Recently, UWDress.com, a professional company of women’s dresses ... newly announced evening cocktail dresses . As a ... outfits are very popular among worldwide customers. Now, all ... (up to 65 percent off). , All UWDress.com’s ... occasion outfits for the global clients. The company is ...
Breaking Medicine News(10 mins):Health News:Angeldress.co.uk Launches New Range Of 2014 Vintage Wedding Dresses In Its Online Store 2Health News:Top10BestSEOHosting.com: FatCow, GoDaddy And Bluehost Are The Best VPS Hosting Suppliers 2Health News:Pixel Film Studios Released Transpack Vol. 3 Plugin Exclusively for Final Cut Pro X 2Health News:Statistics Reveal That the Number of 'Older' First-Time Mothers Is Growing 2Health News:Statistics Reveal That the Number of 'Older' First-Time Mothers Is Growing 3Health News:Statistics Reveal That the Number of 'Older' First-Time Mothers Is Growing 4Health News:Cheap Evening Cocktail Dresses Recently Introduced At UWDress.com 2
... Free Fertility ... see a fertility specialist. With a few clicks of a mouse, women receive a personalized ... ... Schumann, President of the Consumer Services Division of IntegraMed announced today the launch of Free ...
... , ... to Spearhead Company,s Quality, Regulatory and Compliance Matters , ... Panama City, Fla. (PRWEB) April 26, 2010 -- ... the appointment of Samuel Patton as the company’s chief quality and regulatory officer. He ...
... ... to help businesses in Maryland, Virginia and the District of Columbia determine if their leases ... important lease clauses. CA Commercial is also offering “New Lease Review” for Franchise systems to ... ...
... increase the risk of breast cancer among white women have ... Cancer , a peer-reviewed journal of the American Cancer ... how breast cancer risk factors differ among ethnic and racial ... and racial groups, but the reasons behind these differences are ...
... ... special celebrity appearance with launching her latest and greatest new hot fitness machine, ... Hit, the Ab Circle Pro, JNL,s Ab Circle Mini is half the size, ... the same results. Her Management Team has confirmed the following day for her ...
... ... ... launch of two new websites, it’s new and improved consumer site www.thewileyprotocol.com . ... ,These sites are the result of one year of analysis, design, and programming. Our ...
Cached Medicine News:Health News:Fertility Check Educates Women About Infertility; IntegraMed Launches Interactive Assessment Tool 2Health News:Fertility Check Educates Women About Infertility; IntegraMed Launches Interactive Assessment Tool 3Health News:iSirona Appoints Chief Quality and Regulatory Officer to Oversee Quality Initiatives 2Health News:CA Commercial Realty Partners Announces “Free Lease Review for local Businesses" 2Health News:Breast cancer risk factors differ among races 2Health News:Global Premiere: Jennifer Nicole Lee, Super Fitness Model & Mega Brand, Reveals Ab Circle Mini on HSN's World Launch 2Health News:Global Premiere: Jennifer Nicole Lee, Super Fitness Model & Mega Brand, Reveals Ab Circle Mini on HSN's World Launch 3Health News:New Wiley Protocol Web Site Launches 2Health News:New Wiley Protocol Web Site Launches 3
... Super High Density, multi-frequency, linear ... "twist on the UST-5536, this ... it sweeps horizontally as well ... axis so that target lesions ...
Super High Density, multi-frequency, end-fire phased array transducer. Point-and-shoot scanning is the benefit of this transducer....
This is a 3D transducer for endovaginal imaging in OB/GYN....
This is a 3D transducer for endovaginal imaging in OB/GYN....
Medicine Products: